{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:14:38Z","timestamp":1790540078690,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-15-ACN-06"],"award-info":[{"award-number":["1-15-ACN-06"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM075762"],"award-info":[{"award-number":["T32 GM075762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejphar.2018.07.014","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T19:11:14Z","timestamp":1532027474000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers"],"prefix":"10.1016","volume":"834","author":[{"given":"Trung T.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusan","family":"Hesek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7432-0427","authenticated-orcid":false,"given":"Mijoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio L.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Suckow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Mobashery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayland","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.07.014_bib1","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.07.014_bib2","unstructured":"Centers for Disease Control and Prevention, 2017. National Diabetes Statistics Report: Estimate of diabetes and its burden in the United States."},{"key":"10.1016\/j.ejphar.2018.07.014_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.phrs.2016.03.008","article-title":"Restructuring of the extracellular matrix in diabetic wounds and healing: a perspective","volume":"107","author":"Chang","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2018.07.014_bib4","series-title":"Matrix Metalloproteinase Protocols","first-page":"471","article-title":"Mechanism-based profiling of MMPs","author":"Fisher","year":"2010"},{"key":"10.1016\/j.ejphar.2018.07.014_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejvs.2013.03.024","article-title":"Short and long term mortality rates after a lower limb amputation","volume":"46","author":"Fortington","year":"2013","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.ejphar.2018.07.014_bib6","doi-asserted-by":"crossref","first-page":"15226","DOI":"10.1073\/pnas.1517847112","article-title":"Acceleration of diabetic wound healing using a novel protease-anti-protease combination therapy","volume":"112","author":"Gao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2018.07.014_bib7","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/dmrr.847","article-title":"The biology of chronic foot ulcers in persons with diabetes","volume":"24","author":"Gary Sibbald","year":"2008","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ejphar.2018.07.014_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/cb4005468","article-title":"A chemical biological strategy to facilitate diabetic wound healing","volume":"9","author":"Gooyit","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejphar.2018.07.014_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-159-8-201310150-00006","article-title":"Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: a systematic review","volume":"159","author":"Greer","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2018.07.014_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-0115(00)00136-1","article-title":"Reactive oxygen species as mediators of angiotensin II signaling","volume":"91","author":"Griendling","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2018.07.014_bib11","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.1073634","article-title":"S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death","volume":"297","author":"Gu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2018.07.014_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejphar.2018.07.014_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.regpep.2007.12.005","article-title":"Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells","volume":"147","author":"Guo","year":"2008","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2018.07.014_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0022034509359125","article-title":"Factors affecting wound healing","volume":"89","author":"Guo","year":"2010","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ejphar.2018.07.014_bib15","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1021\/jo060058h","article-title":"Synthesis of an inhibitor-tethered resin for detection of active matrix metalloproteinases involved in disease","volume":"71","author":"Hesek","year":"2006","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejphar.2018.07.014_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1524-475X.2005.00074.x","article-title":"Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers","volume":"13","author":"Margolis","year":"2005","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.ejphar.2018.07.014_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008548.pub2","article-title":"Growth factors for treating diabetic foot ulcers","author":"Marti-Carvajal","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2018.07.014_bib18","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2018.07.014_bib19","series-title":"Wound Healing: New Insights into Ancient Challenges","first-page":"37","article-title":"Roles of matrix metalloproteinases in cutaneous wound healing","author":"Nguyen","year":"2016"},{"key":"10.1016\/j.ejphar.2018.07.014_bib20","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1523\/JNEUROSCI.19-19-08464.1999","article-title":"Matrix metalloproteinase-9\/gelatinase B is required for process outgrowth by oligodendrocytes","volume":"19","author":"Oh","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.07.014_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2337\/dc13-2176","article-title":"Burden of diabetic foot ulcers for medicare and private insurers","volume":"37","author":"Rice","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2018.07.014_bib22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/01.PRS.0000047403.23105.66","article-title":"Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7)","volume":"111","author":"Rodgers","year":"2003","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.ejphar.2018.07.014_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2337\/db15-0453","article-title":"Restoration of Nrf2 signaling normalizes the regenerative niche","volume":"65","author":"Soares","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2018.07.014_bib24","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.PRS.0000105044.03230.F4","article-title":"Validation of a model for the study of multiple wounds in the diabetic mouse (db\/db)","volume":"113","author":"Sullivan","year":"2004","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.ejphar.2018.07.014_bib25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.LAB.0000017372.76297.EB","article-title":"Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways","volume":"82","author":"Tamarat","year":"2002","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2018.07.014_bib26","first-page":"163","article-title":"Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography","volume":"57","author":"Toth","year":"2001","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.ejphar.2018.07.014_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nmeth.2371","article-title":"Zymography methods for visualizing hydrolytic enzymes","volume":"10","author":"Vandooren","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejphar.2018.07.014_bib28","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCRESAHA.114.303045","article-title":"Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift","volume":"114","author":"Vukelic","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2018.07.014_bib29","series-title":"The Protein Protocols Handbook. Springer Protocols Handbook","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59745-198-7_3","article-title":"The bicinchoninic acid (BCA) assay for protein quantification","author":"Walker","year":"2009"},{"key":"10.1016\/j.ejphar.2018.07.014_bib30","doi-asserted-by":"crossref","first-page":"13209","DOI":"10.1074\/jbc.M509771200","article-title":"A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation","volume":"281","author":"Yahata","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.07.014_bib31","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.freeradbiomed.2013.09.017","article-title":"On the use of L-012, a luminol-based chemiluminescent probe, for detecting superoxide and identifying inhibitors of NADPH oxidase: a reevaluation","volume":"65","author":"Zielonka","year":"2013","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.ejphar.2018.07.014_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.ASW.0000392922.30229.b3","article-title":"A matched cohort study of the risk of cancer in users of becaplermin","volume":"24","author":"Ziyadeh","year":"2011","journal-title":"Adv. Skin. Wound Care"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:22:42Z","timestamp":1757974962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918303819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":32,"alternative-id":["S0014299918303819"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.014","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}